GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » REMSleep Holdings Inc (OTCPK:RMSL) » Definitions » Cash Conversion Cycle

REMSleep Holdings (REMSleep Holdings) Cash Conversion Cycle : 379.99 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is REMSleep Holdings Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

REMSleep Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 325.89.
REMSleep Holdings's Days Inventory for the three months ended in Dec. 2023 was 57.18.
REMSleep Holdings's Days Payable for the three months ended in Dec. 2023 was 3.08.
Therefore, REMSleep Holdings's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 379.99.


REMSleep Holdings Cash Conversion Cycle Historical Data

The historical data trend for REMSleep Holdings's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

REMSleep Holdings Cash Conversion Cycle Chart

REMSleep Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1,509.55 220.66

REMSleep Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,347.75 1,228.32 1,775.67 1,715.92 379.99

Competitive Comparison of REMSleep Holdings's Cash Conversion Cycle

For the Medical Devices subindustry, REMSleep Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


REMSleep Holdings's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, REMSleep Holdings's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where REMSleep Holdings's Cash Conversion Cycle falls into.



REMSleep Holdings Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

REMSleep Holdings's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=18.79+219.34-17.47
=220.66

REMSleep Holdings's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=325.89+57.18-3.08
=379.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


REMSleep Holdings  (OTCPK:RMSL) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


REMSleep Holdings Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of REMSleep Holdings's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


REMSleep Holdings (REMSleep Holdings) Business Description

Traded in Other Exchanges
N/A
Address
14175 ICOT Blvd, Suite 300, Clearwater, FL, USA, 33760
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The company offers the product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group functions through the region of the United States.
Executives
Russell Finlay Bird 10 percent owner, officer: President 722 50TH STREET, DES MOINES IA 50312
Tom J Wood director, officer: CEO 1170 CHERRYWOOD RD, WAYCROSS GA 31503
Thomas Brookes director, officer: VP & MD OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN 5G2
Matthew Sullivan director, officer: ASST. VP OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN5G2
David M Barnes officer: Chief Financial Officer 6800 JERICHO TURNPIKE, SUITE 208E, SYOSSET NY 11791
Walter Leslie Thistle director, other: Chairman of the Board 17 COLLINGWOOD CRESCENT, MOUNT PEARL A4 A1N5C6
Kat Exploration Inc. 10 percent owner 1149 TOPSAIL ROAD, MOUNT PEARL A4 A1N5G2
Ken Stead director, 10 percent owner, officer: CEO and President 15 BLADE CRESCENT, MOUNT PEARL A4 A1N 5L1
Ronald Davis officer: PRESIDENT 4412 8TH STREET SW, VERO BEACH FL 32968

REMSleep Holdings (REMSleep Holdings) Headlines

From GuruFocus

REMSleep 510K Submission

By Marketwired Marketwired 10-28-2021

REMSleep 510K

By GlobeNewswire GlobeNewswire 06-02-2021

REMSleep Patent Application

By Marketwired Marketwired 11-20-2020

Deltawave CPAP Interface Mask

By Marketwired Marketwired 07-06-2021

REMSleep Patent Application

By GlobeNewswire GlobeNewswire 11-20-2020

Condensation Testing Per ISO 18562-4:2017

By GuruFocusNews GuruFocusNews 01-05-2022